Healthcare >> CEO Interviews >> February 23, 2009
CARL A. PELZEL, President and Chief Executive Officer of Depomed, Inc., joined
the company in June 2005 as Vice President of Marketing and Commercial
Development. In September 2005, he was appointed Executive Vice President and
Chief Operating Officer, a position he held until being appointed President and
Chief Executive Officer in August 2007. Before joining Depomed, Mr. Pelzel was
Senior Vice President, Global Commercial Operations at Chiron Corporation. Under
his leadership, Chiron Biopharmaceuticals generated sales on a global basis
through operations in North America and Europe as well as through a network of
international distributors. Prior to joining Chiron, Mr. Pelzel served as
President and Chief Executive Officer of Invenux Inc., a privately held
biopharmaceutical company. Mr. Pelzel also spent 11 years with GlaxoSmithKline
in senior-level sales, marketing and international operational positions,
including country manager of Hong Kong and China. He spent 13 years with
American Home Products, focused primarily on the company's antibiotics business.
During his career, he directed the launch of five major pharmaceutical products,
many on a global basis. Mr. Pelzel received a BA degree from Hartwick College of
Oneonta, New York, and a Master's degree in Natural Sciences from the University
of Paris. Profile
the things that you are doing now?
Mr. Pelzel: Depomed started out in 1995; it was founded by Dr. John Shell
